Secondary Logo

Journal Logo

January 2014 - Volume 37 - Issue 1
pp: 1-62

Gemcitabine, Oxaliplatin, Levofolinate, 5-Fluorouracil, Granulocyte-Macrophage Colony-Stimulating Factor, and Interleukin-2 (GOLFIG) Versus FOLFOX Chemotherapy in Metastatic Colorectal Cancer Patients: The GOLFIG-2 Multicentric Open-label Randomized Phase III Trial

Correale, Pierpaolo; Botta, Cirino; Rotundo, Maria S.; More

Journal of Immunotherapy. 37(1):26-35, January 2014.

A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine For Patients With Advanced Pancreatic Cancer

Suzuki, Nobuaki; Hazama, Shoichi; Ueno, Tomio; More

Journal of Immunotherapy. 37(1):36-42, January 2014.

A Phase I Trial of Bortezomib and Interferon-a-2b in Metastatic Melanoma

Markowitz, Joseph; Luedke, Eric A.; Grignol, Valerie P.; More

Journal of Immunotherapy. 37(1):55-62, January 2014.